AAVrh32.33 Capsid Shows Unexpected Dermal Tropism, Enhancing Skin Gene Therapy Delivery
AAVrh32.33 capsid Demonstrates Unexpected Dermal Tropism Regardless of Immunodominant Epitope.
Abstract
AAVrh32.33 capsid demonstrates potent and unexpected dermal tropism, making it an effective vector for targeting stromal compartments in cutaneous gene therapy.